Our projects

Understanding mpox virus infectionsThe MOVIE-TRACE project is clarifying two key aspects of mpox infections: the speed at which the virus is cleared from the body and its infectiousness.

Antibiotic-based combination therapy for severe malaria and bacterial bloodstream infectionsThe FACT project is developing an innovative treatment that targets both severe malaria and...

Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...

Advancing monoclonal antibodies to treat HIV in infantsThe ENABLE project is assessing whether broadly neutralising antibodies could make the HIV virus undetectable in young infants.

Automating parasite egg detectionThe DIDIDI project is developing automated systems and AI tools to provide a more rapid assessment of parasitic worm burdens.

Protecting contacts of Bundibugyo patientsThe EBO-PEP 2026 project is assessing whether an antiviral can prevent disease in individuals who have had close contact with patients with Ebola...

Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...

Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...

Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.

Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...

Progressing a multifunctional antimalarialThe RAMP project is advancing the development of a novel antimalarial drug with the potential to both treat the disease and block the transmission...

Treating epilepsy caused by parasite infection  The NeuroSolve project is evaluating a new treatment for patients who develop epileptic seizures when tapeworm larvae become lodged in their...

Reaching those missing out on vaccinationThe REACH-OUT project is developing strategies to ensure that more ‘zero-dose’ children – those missing out entirely on the benefits of vaccines –...

Supporting mpox responses and research in eastern DRCThe MBOTE-SK project is embedding research within the response to the new clade Ib mpox outbreak in eastern DRC.

Detecting TB in childrenThe OPTIC-TB project is assessing whether the use of WHO-recommended clinician guidance (treatment-decision algorithms, TDAs) can improve the detection of...

Building research oversight capacity in Côte d’IvoireThe CECABI II project is developing the capacity of research ethics bodies in Côte d’Ivoire and enhancing coordination with its national...

Building regulatory capacity in West AfricaThe ECOWAS-RegECs project is helping to build regulatory and ethics capacity by simulating scientific advice and review of Lassa fever vaccine...

Strengthening clinical trial oversight in East AfricaThe RER-CTO project is strengthening clinical trial oversight capacity and harmonising regulatory processes in Ethiopia and Tanzania.

Building capacity in health data analysisThe BRIDGE NETWORK project is establishing five centres of excellence to build skills in the use of health data to address key health challenges in...